Skip to main content

Table 1 Effect of kaempferol-3-O-alpha-L-rhamnoside on viable Ehrlich ascites carcinoma (EAC) cell growth

From: Anti-tumor and antioxidant activity of kaempferol-3-O-alpha-L-rhamnoside (Afzelin) isolated from Pithecellobium dulce leaves

Group

Treatment

Viable EAC cells on day 7 after inoculation (× 107 cells/ml)

Percentage (%) cell growth inhibition

1

EAC Cell

7.51 ± 0.83

 

2

EAC + Sz-02 (50 mg/kg)

2.16 ± 0.38*

70.89 ± 6.62*

3

EAC + Sz-02 (25 mg/kg)

4.674 ± 0.28*

37.17 ± 7.94*

4

Vincristine (6.25 mg/kg)

1.64 ± 0.51*

77.84 ± 6.89*

  1. Data are expressed as mean ± SD (n = 5); Analysis of variance followed by LSD and Dunnett’t post hoc test (IBM-SPSS/20)
  2. *P < 0.05: Significance difference with respect to EAC control